Delivra Corp Stock

Stocks

DVA

CA24701U1057

Investment Holding Companies

Delayed Toronto S.E. 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Delivra Corp +2.50% +67.35%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Sales & Marketing - 04/10/2017
Corporate Officer/Principal - 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.50% - - 0
+15.97%+13.49% - - 1.58B
+0.14%+0.14% - - 1.28B
+8.96%+26.74%+447.23%-63.86% 683M
-0.10%+0.10% - - 642M
-9.15%+72.00%+437.72%+306.81% 709M
+0.19%0.00% - - 597M
-0.19%+0.19% - - 592M
-0.35%-0.09% - - 559M
Average +1.49%+17.10%+442.48%+121.48% 830.13M
Weighted average by Cap. +3.52%+15.20%+442.39%+124.81%
Logo Delivra Corp
Delivra Corp., formerly Whiteknight Acquisitions III Inc., is a developer of transdermal technologies for the delivery of pharmaceutical and natural molecules through the skin. The Company manufactures and sells natural topical creams under its brand names, LivRelief, which is indicated for conditions, including joint and muscle pain, nerve pain, circulation and wound healing, and LivSport brand, which is indicated for sports performance. Its business is divided into two areas of focus: Consumer Healthcare Over the Counter (OTC) Retail products, and Technology Licensing. Its OTC natural topical products include LivRelief Pain Relief Cream, LivRelief Varicose Vein Cream, LivRelief Nerve Pain Relief Cream, LivRelief Healing Cream, LivSport Pre-Workout Cream and LivSport Post-Workout Cream. It utilizes Delivra transdermal delivery system, a platform that enables through-the-skin penetration and delivery of a range of active ingredients intended to treat various symptoms and conditions.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!